papaverine and satigrel

papaverine has been researched along with satigrel in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, K; Kobayashi, S; Nagakura, N; Saeki, T; Saito, I; Yamanaka, T; Yoshitake, S	1

Other Studies

1 other study(ies) available for papaverine and satigrel

Article	Year
Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities. Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:6 Topics: Blood Platelets; Cilostazol; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Fatty Acids, Monounsaturated; Humans; In Vitro Techniques; Isoenzymes; Male; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboxane A2	1996

Article

Year

Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.

Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:6

Topics: Blood Platelets; Cilostazol; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Fatty Acids, Monounsaturated; Humans; In Vitro Techniques; Isoenzymes; Male; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboxane A2

1996